sula vineyards' rajeev samant exclusive on the firm's q3 results & 2023 outlook | cnbc-tv18
Published 1 year ago • 533 plays • Length 5:01Download video MP4
Download video MP3
Similar videos
-
7:56
sula vineyards' rajeev samant exclusive on the firm's healthy q3fy23 results | cnbc-tv18
-
6:11
sula vineyards' ceo rajeev samant, in conversation with cnbc tv18 on q3 results
-
5:51
share buyback benefits the eps as well as the valuation metrics & even the shareholders: symphony
-
9:12
sula vineyards' rajeev samant exclusive on the firm's business outlook & demand trends | cnbc-tv18
-
11:12
sula vineyards' ceo rajeev samant, in conversation with ndtv profit fy24 financial results
-
7:30
sula vineyards:weaker q4 impacted the company growth,how company will improve their margins in fy25?
-
7:28
syrma sgs md expands on q1 results & growth in consumer it and railway sector
-
0:58
gold etfs vs funds vs sovereign gold bonds? | n18s | cnbc tv18
-
8:10
what are the key stocks & sectors in focus today? | cnbc tv18
-
6:42
rajeev samant of sula vineyards speaks on filing ipo papers & the firm's growth plans | trading hour
-
5:41
what are the key stocks & sectors in focus today? | cnbc tv18
-
9:56
rajeev samant discusses sula vineyard's growth outlook & more | bazaar corporate radar | cnbc-tv18
-
7:40
rajeev samant in conversation with cnbc tv18 on continuation of the wine industrial promotion scheme
-
0:52
increased us unemployment rate triggers the sahm rule | what happens next? n18s | cnbc tv18
-
11:30
crypto market rebounds after global equity sell-off | cnbc tv18
-
9:30
rajeev samant discusses sula vineyards' capex plans, business outlook | chartbusters | cnbc-tv18
-
8:19
premium segment growth will continue to be in double digit: sula vineyards | cnbc tv18
-
3:09
symphony q1 results; ebitda margin surges from 8.6% to 20.9% yoy, board approves ₹71.40 cr buyback
-
10:08
premium portfolio has outperformed cheaper wines and will continue to do so in fy25: sula vineyards
-
1:18
divi's laboratories q1: revenue grows, profit below est; mgmt positive on glp-1 drug opportunities
-
4:16
rajeev samant discusses sula vineyards' ipo & outlook going ahead | trading hour | cnbc-tv18